12 November 2014
Applications have opened for UK researchers and clinicians to join the new Genomics England Clinical Interpretation Partnership (GeCIP).
The goal of the GeCIP is to bring together ‘the best researchers in the UK alongside their key international collaborators’ to maximise the potential of new biological insights into rare inherited diseases, cancers and infectious diseases from the 100,000 Genomes Project database.
Genomics England says that bringing multidisciplinary researchers and the NHS onboard at this early stage of the project will accelerate translation of research findings into earlier diagnoses for patients, notably without the traditional delay from publication of research findings to adoption in healthcare practice.
Chief Scientist Professor Mark Caulfield observed that a “coalition of intellects” was needed for an interactive approach to “interpret and use this incredible resource for the benefit of current and future patients”.
Life Sciences Minister George Freeman encouraged researchers and health professionals to participate, saying: “We want to make the UK the best place in the world to discover 21st century medicines”.
According to the Financial Times, the 100,000 Genomes Project has received £164m in funding from governmental bodies including the NHS, as part of the £300m investment announced by the government in August. Part of this is being used to create a dedicated project centre at the Wellcome Trust Genome Campus just outside Cambridge.
Wellcome's head of genetics and molecular sciences Michael Dunn said: “The UK has an advantage in medical genomics because the integrated health service will allow it to compare a lot of genomic information for statistical analyses”.